Cargando…
Quantitative Model for Efficient Temporal Targeting of Tumor Cells and Neovasculature
The combination of cytotoxic therapies and antiangiogenic agents is emerging as a most promising strategy in the treatment of malignant tumors. However, the timing and sequencing of these treatments seem to play essential roles in achieving a synergic outcome. Using a mathematical modeling approach...
Autores principales: | Kohandel, M., Haselwandter, C. A., Kardar, M., Sengupta, S., Sivaloganathan, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065043/ https://www.ncbi.nlm.nih.gov/pubmed/21461349 http://dx.doi.org/10.1155/2011/790721 |
Ejemplares similares
-
Vaccines targeting the neovasculature of tumors
por: Matejuk, Agata, et al.
Publicado: (2011) -
Extracellular Vesicles Are Key Regulators of Tumor Neovasculature
por: Kuriyama, Naoya, et al.
Publicado: (2020) -
Stochastic model for tumor control probability: effects of cell cycle and (a)symmetric proliferation
por: Dhawan, Andrew, et al.
Publicado: (2014) -
Modeling the Spatial Distribution of Chronic Tumor Hypoxia: Implications for Experimental and Clinical Studies
por: Powathil, Gibin, et al.
Publicado: (2012) -
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors
por: Mortensen, Michael R., et al.
Publicado: (2020)